Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „avanafil“
Suchtreffer
Begriffe & Kennungen
Kaletra · 4.3 · 78 Phosphodiesterase Avanafil Increased plasma concentrations of (PDE5) inhibitors avanafil (see sections 4.4
Eintrag öffnenNorvir · 4.5 · Phosphodiesterase (PDE5) inhibitors Avanafil 50, single dose 600 q12h ↑ 13-fold ↑ 2.4-fold Concomitant use of
Eintrag öffnenNorvir · 4.5 · Phosphodiesterase (PDE5) inhibitors Avanafil 50, single dose 600 q12h ↑ 13-fold ↑ 2.4-fold Concomitant use of
Eintrag öffnenSpedra · 4.3 · The co-administration of type 5 phosphodiesterase (PDE5) inhibitors, including avanafil, with guanylate cyclas
Eintrag öffnenSpedra · 4.3 · The co-administration of type 5 phosphodiesterase (PDE5) inhibitors, including avanafil, with guanylate cyclas
Eintrag öffnenSpedra · 4.3 · The co-administration of type 5 phosphodiesterase (PDE5) inhibitors, including avanafil, with guanylate cyclas
Eintrag öffnenSpedra · 4.3 · The use of avanafil is contraindicated in:
Eintrag öffnenSpedra · 4.3 · The use of avanafil is contraindicated in:
Eintrag öffnenSpedra · 4.3 · The use of avanafil is contraindicated in:
Eintrag öffnenSpedra · 4.5 · 19 Although specific interactions of avanafil with rivaroxaban and apixaban (both CYP3A4 substrates) have not
Eintrag öffnenSpedra · 4.5 · 32 Although specific interactions of avanafil with rivaroxaban and apixaban (both CYP3A4 substrates) have not
Eintrag öffnenSpedra · 4.5 · 6 Although specific interactions of avanafil with rivaroxaban and apixaban (both CYP3A4 substrates) have not b
Eintrag öffnenSpedra · 4.5 · Alcohol Consumption of alcohol in combination with avanafil can increase the potential for symptomatic hypoten
Eintrag öffnenSpedra · 4.5 · Alcohol Consumption of alcohol in combination with avanafil can increase the potential for symptomatic hypoten
Eintrag öffnenSpedra · 4.5 · Alcohol Consumption of alcohol in combination with avanafil can increase the potential for symptomatic hypoten
Eintrag öffnenSpedra · 4.5 · Antihypertensives other than alpha-blockers A clinical study was conducted to assess the effect of avanafil on
Eintrag öffnenSpedra · 4.5 · Antihypertensives other than alpha-blockers A clinical study was conducted to assess the effect of avanafil on
Eintrag öffnenSpedra · 4.5 · Antihypertensives other than alpha-blockers A clinical study was conducted to assess the effect of avanafil on
Eintrag öffnenSpedra · 4.5 · Based on in vitro data, at clinically relevant concentrations avanafil could be an inhibitor of BCRP. At clini
Eintrag öffnenSpedra · 4.5 · Based on in vitro data, at clinically relevant concentrations avanafil could be an inhibitor of BCRP. At clini
Eintrag öffnen